PDUFA V: What you need to know about the upcoming Prescription Drug User Fee Act
Rho
19-Mar-2012 - A SEC filing has created speculation that Medidata is the target of a private equity takeover attempt by Vista Equity Partners.
14-Mar-2012 - Icon wants to create a “jigsaw” of patient recruitment vendors to speed enrolment and differentiate it from other CROs.
13-Mar-2012 - The Pfizer virtual trial, innovative clinical technologies, and globalisation dominated discussions at Partnerships in Clinical Trials 2012. Here’s what your peers made of the event…
12-Mar-2012 - The two Indian CROs implicated in US TV show Dateline’s recent undercover operation have branded the report “unfair” and “out of context”.
12-Mar-2012 - Large pharma companies are seeking co-development deals to handle excess intellectual property, INC said.
08-Mar-2012 - Icon views its imaging deal with Roche as a “step towards breaking in with the [Swiss pharma]”, its president said.
07-Mar-2012 - Small biopharma companies need a sizable pipeline of work to guarantee attention from big CROs, speakers at PCT said.
07-Mar-2012 - Quintiles’ CEO says CROs need to evolve with Pharmas, take opportunities in emerging markets and help customers demonstrate value to a growing number of stakeholders.
06-Mar-2012 - The head of Pfizer's virtual clinical trial has defended the project after its initial failure to recruit patients raised questions about its viability.
05-Mar-2012 - Icon will manage all of Roche’s medical images under a new technology partnership announced today.
01-Mar-2012 - More evidence Russia’s Ministry of Health (MoH) may be getting better at approving trials emerged this week - at least when it comes to international studies.
29-Feb-2012 - ERT ended 2011 on a high as its decision to stop ‘walking away from business’ helped it post double-digit sales growth.
28-Feb-2012 - Quintiles is driving its clinical development services in the Russian Federation through a new alliance with Russian Venture Company (RVC).
23-Feb-2012 - S&P is predicting up to high single-digit near-term growth at Quintiles but rising costs and early phase capacity issues will pressure profits.
23-Feb-2012 - Inclinix has teamed up with JSW Life Sciences in a bid to ramp up its European patient recruitment capabilities.
23-Feb-2012 - Premier Research has doubled its clinical trials testing capacity with the launch of two research facilities in Phoenix and Salt Lake City, US.
22-Feb-2012 - China-based CRO Wuxi PharmaTech has repurchased shares from private equity fund General Atlantic LLC.
21-Feb-2012 - ACRO has told HHS the Physician Payments Sunshine Act is “highly problematic” for drug research and CROs in the US.
20-Feb-2012 - CROs Venn Life Sciences and Encorium are to merge and have secured working capital to expand the business.
20-Feb-2012 - The value of RFPs sent to Icon in 2011 jumped 50 per cent as companies that have yet to ink strategic deals began bundling services.
16-Feb-2012 - Fourth quarter earnings at Icon missed analyst estimates and its guidance as an uptick in sales failed to offset rising costs.
15-Feb-2012 - Ockham has expanded its oncology trial services offering through its acquisition of Nexus Oncology.
14-Feb-2012 - SeraCare Life Sciences has accepted an $82m offer from a US private equity firm six months after it began searching for a buyer.
09-Feb-2012 - Bioclinica says pricing in the clinical imaging sector has stabilised as Pharmas have opted to work with fewer service providers.
08-Feb-2012 - Celerion has teamed up with Verified Clinical Trials (VCT), a group aiming to stop ‘professional patients’ enrolling in multiple trials.